BeiGene (ONC) said Tuesday it has changed its name to BeOne Medicines and completed its redomiciliation to Switzerland.
The company said its shareholders approved the new name and redomiciliation to Switzerland from the Cayman Islands on April 28.
The transition to its new name throughout its global operations will take effect in phases, the company added.
BeOne's shares were up more than 1% in early trading Tuesday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.